Drug Type Drug conjugates |
Synonyms |
Target |
Mechanism α-synuclein inhibitors(Synuclein alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Autotac Bio, Inc.Startup |
Active Organization Autotac Bio, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | KR | Autotac Bio, Inc.Startup | 23 Jan 2024 |